VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $802,073 | -36.8% | 6,432,023 | -47.8% | 0.00% | – |
| Q4 2022 | $1,269,530 | +48.1% | 12,325,542 | +118.8% | 0.00% | – |
| Q3 2022 | $857,000 | -75.0% | 5,632,066 | +44.6% | 0.00% | – |
| Q2 2022 | $3,428,000 | -23.4% | 3,895,398 | +7.9% | 0.00% | – |
| Q1 2022 | $4,476,000 | -73.3% | 3,609,840 | -58.0% | 0.00% | -100.0% |
| Q4 2021 | $16,770,000 | -22.1% | 8,600,234 | +9.5% | 0.00% | 0.0% |
| Q3 2021 | $21,523,000 | +123.3% | 7,855,139 | +156.7% | 0.00% | 0.0% |
| Q2 2021 | $9,638,000 | – | 3,059,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|